With the market barely under way, leading international experts from Europe and the USA talk about the potential for CBG in this special HempTALKS roundtable. Like THC and CBD, CBG is one of 120 cannabinoids found in cannabis and is getting a lot of attention from farmers, processors, marketers and investors. While cannabis stakeholders have long been focused on developing THC and CBD, researchers and hemp breeders are now teaming up to better understand CBG, and developing CBG-rich cultivars. CBG is known as the “mother” or “OG” cannabinoid, and could hold the cumulative qualities of all other cannabinoids put together.
Time stamps to the roundtable:
01:28 – Self introduction: Mike Leago
03:18 – Self introduction: Boris Baňas
04:48 – Self introduction: Christy Thiel
05:47 – Background: What is CBG?
07:44 – Health benefits of CBG, and how it works on the body
10:10 – CBG and international drug treaties
12:26 – CBG’s status vis a vis controlled drugs in the USA
14:25 – ‘Mother of all cannabinoids’ – from a scientific perspective
15:27 – Physical form of the compound
16:23 – Kinds of products in which CBG is used
16:46 – CBG & healing professionals: The need for education
19:06 – How many farmers are growing for CBG; end products
20:39 – Varieties (biomass) sourced from European farmers.
20:57 – Pricing of biomass
23:41 – Pricing of isolate and distillate
24:41 – Matterhorn high-CBG strain
27:18 – Matterhorn: Cultivation outside and indoors
Referenced in the roundtable:
Swiss, U.S. firms partner to bring new cultivars to Europe
EIHA fears EU ruling on extracts could strike ‘final blow’ to entire hemp sector
Charlotte Figi, American girl who raised profile of CBD, dies at 13
Mike Leago | Chief Operating Officer | High Grade Hemp Seed
An expert on genetics, farming, supply chain management & consumer goods, Mike is COO at High Grade Hemp Seed (HGH), which focuses on developing hemp seeds with high feminization and germination rates, and high cannabinoid levels. A hemp farmer since 2016 in the U.S. states of Colorado and Oregon, Mike is also Founder and President of International Hemp Exchange (iHEMPx), the first licensed and bonded hemp broker in the United States. Instrumental in creating the recently released Matterhorn CBG strain.
Boris Baňas | Chief Sales Officer | CBDepot
A hemp activist since 1998, Boris started growing hemp for research under Slovakian government licenses in 1999, and ultimately helped to push the government of Slovakia to adopt EU hemp-related farming rules in 2008. He launched CBDepot in 2014 with a mission to provide legal, high quality cannabidiol-enriched products for the industrial and consumer markets. He is also co-founder and co-owner of Hemp Seed Oil Europe, ltd, a supplier of bulk and private label hemp seed derivatives. Boris is a graduate of the School of Finance, Matej Bel University, Slovakia.
Christy Thiel | Director of Education & Partner Relations | Seed2System
In addition to her role at Seed2System, Christy is also a Master Nutrition Therapist and a specialist in ancestral nutrition. At the forefront of the hemp industry expansion, Christy consults and trains companies through education and elevated best practices. Her approach to total wellness includes nutrition with a strong focus on the endocannabinoid system and CBD/Hemp. She speaks globally about wellness and the role of the endocannabinoid system in human health.
Kehrt Reyher, Editor & Publisher, HempToday
Lack of intelligence and data is a challenge to USA Hemp
New compound from CBDA could be substitute for opioids, steroids
Czech firm’s effort to register synthesized CBD for food advances
IP licensing startup aims to connect breeders with market
Wildfires, insect infestations, cold weather, fungus and flooding have all caused major headaches for U.S.…
Poland’s Institute of Natural Fibers & Medicinal Plants (IWNiRZ) has launched a program aimed at…
Two hemp groups in the U.S. state of Kentucky have merged in an effort to…
A fully functioning hemp industry could generate billions in income for New Zealand by 2030…
Australia’s Ministry of Health has handed down an interim decision that could lead to over-the-counter…